BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1378160)

  • 1. Immunocytochemical investigation of normal and chronic lymphocytic leukaemia lymphocytes reveals unexpectedly frequent reactivity with some myelomonocytic associated antibodies.
    Woessner S; Florensa L; Besses C; Vilà RM; Gallés C; Palou L; Sabrafen JS
    Leuk Res; 1992; 16(5):505-10. PubMed ID: 1378160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of bone marrow growth pattern, coexpression of CD14, and B-cell CD5 antigen density in 45 B-chronic lymphocytic leukemia (B-CLL) patients.
    Paglieroni T; Caggiano V; MacKenzie MR
    Ann N Y Acad Sci; 1992 May; 651():484-5. PubMed ID: 1376066
    [No Abstract]   [Full Text] [Related]  

  • 3. Myeloid antigen, CD13, CD14, and/or CD33 expression is restricted to certain lymphoid neoplasms.
    Nakase K; Kita K; Shiku H; Tanaka I; Nasu K; Dohy H; Kyo T; Tsutani H; Kamada N
    Am J Clin Pathol; 1996 Jun; 105(6):761-8. PubMed ID: 8659452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of myelomonocytic antigens is associated with unfavourable clinicoprognostic factors in B-cell chronic lymphocytic leukaemia.
    Pinto A; Del Vecchio L; Carbone A; Roncadin M; Volpe R; Serraino D; Monfardini S; Colombatti A; Zagonel V
    Ann Oncol; 1991 Feb; 2 Suppl 2():107-13. PubMed ID: 2049307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute myeloid leukaemia with an unusual phenotype: myeloperoxidase (+), CD13 (-), CD14 (-) and CD33 (-).
    Seshi B; Kashyap A; Bennett JM
    Br J Haematol; 1992 Jul; 81(3):374-7. PubMed ID: 1382546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myelomonocytic antigens in B-cell chronic lymphocytic leukemia.
    Tàssies D; Montserrat E; Reverter JC; Villamor N; Rovira M; Rozman C
    Leuk Res; 1995 Nov; 19(11):841-8. PubMed ID: 8551801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of chronic lymphoid leukaemias according to FAB.
    Oertel J; Kastner M; Bai AR; Kleiner S; Huhn D
    Leuk Res; 1992 Sep; 16(9):919-27. PubMed ID: 1405721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myelomonocytic associated antigens in B-chronic lymphocytic leukemia: analysis of clinical significance.
    Molica S; Dattilo A; Alberti A
    Leuk Lymphoma; 1991; 5(2-3):139-44. PubMed ID: 21269073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of chronic lymphocytic leukaemia with myeloid associated antigen.
    Kawamata N; Maruyama Y; Toda S; Takase K; Akiyama H; Sakamaki H; Onozawa Y
    Br J Haematol; 1992 Jan; 80(1):129-30. PubMed ID: 1346967
    [No Abstract]   [Full Text] [Related]  

  • 10. Expression of myeloid associated antigens in chronic lymphocytic leukaemia.
    Pinto A; Zagonel V; Carbone A; Del Vecchio L
    Br J Haematol; 1992 Sep; 82(1):173-5. PubMed ID: 1358172
    [No Abstract]   [Full Text] [Related]  

  • 11. Myelomonocytic antigens are rarely expressed on B-lymphocytic leukemia cells.
    Polliack A; Rabinowitz R; Leizerowitz R; Keren-Zur Y; Schlesinger M
    Leuk Lymphoma; 1993 Jan; 9(1-2):125-31. PubMed ID: 8477192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation and high frequency expression of autoantibody-associated cross-reactive idiotypes linked to the VHI subgroup in CD5-expressing B lymphocytes from patients with chronic lymphocytic leukaemia (B-CLL).
    Shokri F; Mageed RA; Richardson P; Jefferis R
    Scand J Immunol; 1993 Jun; 37(6):673-9. PubMed ID: 7686301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD20 and CD5 expression in B-chronic lymphocytic leukemia.
    Marti GE; Faguet G; Bertin P; Agee J; Washington G; Ruiz S; Carter P; Zenger V; Vogt R; Noguchi P
    Ann N Y Acad Sci; 1992 May; 651():480-3. PubMed ID: 1376065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells.
    Hashimoto S; Dono M; Wakai M; Allen SL; Lichtman SM; Schulman P; Vinciguerra VP; Ferrarini M; Silver J; Chiorazzi N
    J Exp Med; 1995 Apr; 181(4):1507-17. PubMed ID: 7535340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia.
    Almasri NM; Duque RE; Iturraspe J; Everett E; Braylan RC
    Am J Hematol; 1992 Aug; 40(4):259-63. PubMed ID: 1380203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4+, CD33-, CD13-, CD14- acute monoblastic leukaemia.
    Lombard EH; Mansvelt EP
    Acta Haematol; 1992; 87(3):151-2. PubMed ID: 1379402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometric analysis of membrane CD11b, CD11c and CD14 expression in acute myeloid leukaemia: relationships with monocytic subtypes and the concept of relative antigen expression.
    Scott CS; Richards SJ; Master PS; Kendall J; Limbert HJ; Roberts BE
    Eur J Haematol; 1990 Jan; 44(1):24-9. PubMed ID: 1689668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinctive features of "nurselike" cells that differentiate in the context of chronic lymphocytic leukemia.
    Tsukada N; Burger JA; Zvaifler NJ; Kipps TJ
    Blood; 2002 Feb; 99(3):1030-7. PubMed ID: 11807009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myelo-monocytoid immunophenotypes of B-cell chronic lymphocytic leukemia cells.
    Tsuda H; Matsumi S; Nishimura H; Kawano F; Shido T; Takatsuki K
    Intern Med; 1993 Jul; 32(7):533-9. PubMed ID: 8286829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface phenotype and Ig heavy-chain gene usage in chronic B-cell leukemias: expression of myelomonocytic surface markers in CD5- chronic B-cell leukemia.
    Ikematsu W; Ikematsu H; Okamura S; Otsuka T; Harada M; Niho Y
    Blood; 1994 May; 83(9):2602-10. PubMed ID: 7513207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.